Reported Consolidated quarterly numbers for Glenmark Pharma are:Net Sales at Rs 2,506.70 crore in December 2023 down 27.63% from Rs. 3,463.86 crore in December 2022.
Quarterly Net Loss at Rs. 351.38 crore in December 2023 down 220.85% from Rs. 290.76 crore in December 2022.
EBITDA stands negative at Rs. 163.24 crore in December 2023 down 123.43% from Rs. 696.66 crore in December 2022.
| Glenmark shares closed at 927.65 on February 26, 2024 (NSE) and has given 20.92% returns over the last 6 months and 114.51% over the last 12 months. |
| Glenmark Pharma | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 2,506.70 | 3,207.38 | 3,463.86 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 2,506.70 | 3,207.38 | 3,463.86 | | EXPENDITURE | | Consumption of Raw Materials | 657.51 | 915.75 | 874.19 | | Purchase of Traded Goods | 413.11 | 408.83 | 454.31 | | Increase/Decrease in Stocks | -38.35 | -126.80 | -162.43 | | Power & Fuel | -- | -- | -- | | Employees Cost | 753.04 | 732.88 | 756.00 | | Depreciation | 147.08 | 141.45 | 162.28 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 930.05 | 814.43 | 921.55 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -355.72 | 320.83 | 457.97 | | Other Income | 45.41 | 1.70 | 76.42 | | P/L Before Int., Excpt. Items & Tax | -310.31 | 322.53 | 534.38 | | Interest | 134.34 | 121.46 | 97.27 | | P/L Before Exceptional Items & Tax | -444.66 | 201.07 | 437.12 | | Exceptional Items | -76.72 | -325.42 | 33.88 | | P/L Before Tax | -521.38 | -124.35 | 471.00 | | Tax | -71.80 | 55.95 | 180.23 | | P/L After Tax from Ordinary Activities | -449.58 | -180.30 | 290.76 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | 118.77 | 118.74 | -- | | Net Profit/(Loss) For the Period | -330.82 | -61.56 | 290.76 | | Minority Interest | -20.56 | -20.38 | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -351.38 | -81.95 | 290.76 | | Equity Share Capital | 28.22 | 28.22 | 28.22 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -12.45 | -2.90 | 9.66 | | Diluted EPS | -12.45 | -2.90 | 9.66 | | EPS After Extra Ordinary | | Basic EPS | -12.45 | -2.90 | 9.66 | | Diluted EPS | -12.45 | -2.90 | 9.66 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
